Abbott Laboratories (ABT) Earnings Call Analysis

NYSE · Healthcare · Medical Devices

Earnings Reports

• Abbott (ABT) Q2 2026: Four Growth Engines Drive 80% of Second-Half Acceleration
  July 16, 2026
• Abbott (ABT) Q1 2026: Exact Sciences Adds $3B Growth Engine, Diagnostics and MedTech Set for H2 Acceleration
  April 16, 2026
• Abbott (ABT) Q4 2025: Medical Device Growth Hits 10.5% as Nutrition Recalibration Weighs on Outlook
  January 22, 2026
• Abbott (ABT) Q3 2025: Medical Devices Surge 12.5% as Portfolio Expansion Drives Durable Growth
  October 15, 2025
• Abbott (ABT) Q2 2025: Medical Devices Surge 12% as Diagnostics Face $1B Headwind
  July 18, 2025
• Abbott (ABT) Q1 2025: Margin Expansion and Diversified Growth Offset Tariff Uncertainty
  June 10, 2025
• Abbott (ABT) Q3 2024: MedTech Surges 13% as Libre, Structural Heart Drive Portfolio Momentum
  October 16, 2024
• Abbott (ABT) Q2 2024: Medical Devices Surge 12% as Margin Expansion Outpaces Peers
  July 18, 2024
• Abbott (ABT) Q1 2024: Medical Devices Surge 14%, Propelling Guidance Raise and Margin Expansion
  April 17, 2024
• Abbott (ABT) Q4 2023: Base Business Grows 11% as Pipeline Delivers New $3B Opportunity
  January 24, 2024

Browse all companies